Sobre nosotros Fuda Cancer Hospital
Under the administration of the Health Commission of Guangdong Province, Guangzhou Fuda Cancer Hospital is an international-oriented oncology-specialized hospital integrating medical care, teaching, scientific research, disease prevention and healthcare. Guided by high and new technologies, it features minimally invasive therapies, and is the first oncology-specialized hospital in Guangdong Province accredited by Joint Commission International (JCI). The hospital consists of the Tianhe Campus and Haizhu Campus, with a total floor area of over 30,000 m², 400 open beds and 45 VIP rooms.
In 2010, the former Ministry of Health designated FUDA Cancer Hospital as one of the first batch of National Key Clinical Cancer Speciality Centres (Oncology). In 2017, the Hospital was awarded the title of Civilized Unit of Guangdong Province. In 2018, the Hospital was officially accredited as a National Key Clinical Specialty (Oncology). In 2019, the Hospital was named a High-level Key Clinical Cancer Speciality Centre of Guangdong Province (Oncology). In 2021, the Hospital Party Committee was conferred the honorary title of Advanced Grassroots Party Organization of Guangdong Province. The Hospital has received multiple honors including National Trustworthy Private Hospital and Top-100 National Trustworthy Demonstration Hospital for the Public. It is a designated medical institution for nationwide inter-provincial on-the-spot medical insurance settlement, a designated unit for provincial-level and municipal-level public-funded medical care of Guangdong, as well as a designated hospital under Guangzhou Municipal Medical Insurance Scheme.
Upholding its hospital motto “Practising medicine with great virtue; advancing medical ethics in solidarity”, and adhering to the hospital-running guidelines “Prospering the hospital through science and technology, sustaining the hospital through integrity, operating the hospital with benevolence”, the hospital pursues a development path of high-end positioning, academic emphasis and international outreach. It has developed the distinctive 3C+P Model of comprehensive personalized care, consisting of Cryo-Irreversible Electroporation Ablation (CIA), Cancer Vascular Intervention (CVI), and Combined Immunotherapy for Cancer (CIC), plus Personalized (P) comprehensive therapy. Patients from more than 130 countries and regions worldwide have been attracted to come, 60 % of whom are from Southeast Asia, the Middle East, Europe and North America.
Guangzhou Fuda Cancer Hospital fosters an institutional culture of “Shouldering responsibilities and devoting to public welfare”, and has long been committed to social welfare initiatives. The hospital has donated funds and supplies for disaster-stricken areas such as the Wenchuan and Ya’an earthquakes, taken part in public-benefit programmes including “Caring-for-People Charity Campaign of Guangzhou”, and established the Fuda Benevolence Foundation. Cumulative donations of funds and materials have exceeded RMB 20 million over the years. The Hospital has provided free physical examinations for more than 10,000 nearby elderly persons living alone. Through community free clinics, health lectures, financial assistance for impoverished patients and other outreach activities, it delivers tangible benefits to the general public and earnestly fulfils its social responsibilities.
Galería de la empresa
Problemas de la industria abordados
Healthcare - Hospital (Oncology specialty)
locally unresectable tumors, systemic metastasis, need to reduce systemic toxicity or preserve organ function with less invasive options
Definiciones de servicio
Comprehensive oncology services (cryoablation, NanoKnife, interventional, chemo/radiotherapy, immunotherapy)
Medical services: oncology specialty clinical care, minimally invasive interventional treatments, immuno‑/cell therapies, rehabilitation and supportive care
Capacidades de servicio
Capacidades de servicio
Soluciones de servicio
3C+P Personalized Comprehensive Oncology Solution (Cryo-NanoKnife, Vascular Intervention, Combined Immunotherapy + Personalization)
Metodologías de servicio
MDT-led personalized 3C+P treatment methodology
Framework: MDT assessment → molecular/imaging diagnostics → personalized combined treatments (cryo/nanoknife/intervention/immuno/chemo-radio) → rehab & follow-up
Procesos de servicio
| Nombre del proceso | Descripción del proceso | Pasos clave | Cronograma | Entregables |
|---|---|---|---|---|
| Patient pathway: Consultation → MDT → Treatment → Follow-up | Overview: online/phone appointment → outpatient assessment → imaging/molecular tests → MDT plan → treatment → rehab & follow-up | - | - | - |
Casos de servicio
Estudio de caso
Industria del cliente: Individual patient (medical/international patient case)
Estudio de caso
Industria del cliente: Case patient background: vehicle mechanic from Guangxi
Estudio de caso
Industria del cliente: Patient is a student (case individual), not an industry client
Estudio de caso
Industria del cliente: Patient (healthcare recipient)
Estudio de caso
Industria del cliente: Patient family from the catering industry (case detail)
Rendimiento del servicio
Videos de la empresa y productos
Introducción a la empresa y tour por la fábrica
⏱ Duration: 3:45 | 👁 Views: 15,230
Demostración del producto - Kestrel K-1
⏱ Duration: 5:12 | 👁 Views: 28,450
showcase de innovación tecnológica
⏱ Duration: 4:30 | 👁 Views: 12,890
Testimonios de clientes y casos de éxito
⏱ Duration: 6:20 | 👁 Views: 9,650
¿Listo para transformar su vida?
Contáctenos ahora para saber cómo nuestros productos pueden satisfacer sus necesidades.